Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

NCT05982561 is registered in ClinicalTrials.gov with Early is Good Inc. as lead sponsor.

NCT NCT05982561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05982561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Lead sponsor
Early is Good Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 26, 2023
Completion date
August 31, 2026
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer